# CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) FY2026 YTD Q2 P&L / Income Statement - Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) - Period: 2025-12-28 to 2026-06-27 - Filing: Q2 FY2026 10-Q, filed 2026-08-05, accession number 0001100682-26-000118 - Page: https://plicit.ai/financials/crl/fy2026-ytd-q2-income-statement - Chart image: https://plicit.ai/charts/crl-fy2026-ytd-q2-income-statement-sankey.png ## Chart details: Revenue by Product and Service Income statement for 2025-12-28 through 2026-06-27. View: Product and service. Revenue and costs use their disclosed categories. - **Total revenue**: 1,999,908,000 US dollars - **Cost of revenue (calculated)**: 1,341,870,000 US dollars - **Gross profit (calculated)**: 658,038,000 US dollars - **Operating expenses (calculated)**: 418,253,000 US dollars - **Operating income**: 239,785,000 US dollars - **Other income (expense), net (calculated)**: negative 216,557,000 US dollars - **Income before income taxes**: 23,228,000 US dollars - **Provision for income taxes**: 38,790,000 US dollars - **Net income (loss)**: negative 15,562,000 US dollars - **Service revenue**: 1,606,439,000 US dollars - **Product revenue**: 393,469,000 US dollars - **Service cost of revenue**: 1,160,914,000 US dollars - **Product cost of revenue**: 180,956,000 US dollars - **Amortization of intangible assets**: 29,934,000 US dollars - **Selling, general and administrative**: 388,319,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. - Of which attributable to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: −$16.33 M; to noncontrolling interests: $763.00 K. ## Chart details: Revenue by Business Segment - Page: https://plicit.ai/financials/crl/fy2026-ytd-q2-income-statement/revenue-by-business-segment - Chart image: https://plicit.ai/charts/crl-fy2026-ytd-q2-revenue-by-business-segment-sankey.png Income statement for 2025-12-28 through 2026-06-27. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total revenue**: 1,999,908,000 US dollars - **Cost of revenue (calculated)**: 1,341,870,000 US dollars - **Gross profit (calculated)**: 658,038,000 US dollars - **Operating expenses (calculated)**: 418,253,000 US dollars - **Operating income**: 239,785,000 US dollars - **Other income (expense), net (calculated)**: negative 216,557,000 US dollars - **Income before income taxes**: 23,228,000 US dollars - **Provision for income taxes**: 38,790,000 US dollars - **Net income (loss)**: negative 15,562,000 US dollars - **Research Models and Services Segment**: 417,842,000 US dollars - **Discovery and Safety Assessment Segment**: 1,203,430,000 US dollars - **Manufacturing**: 378,636,000 US dollars - **Cost of revenue (excluding amortization of intangible assets)**: 1,341,870,000 US dollars - **Amortization of intangible assets**: 29,934,000 US dollars - **Selling, general and administrative**: 388,319,000 US dollars - **Research Models and Services Segment costs (calculated)**: 331,792,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. - **Discovery and Safety Assessment Segment costs (calculated)**: 975,156,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. - **Manufacturing costs (calculated)**: 266,191,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. - **Reconciling items (calculated)**: 186,984,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. - Of which attributable to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: −$16.33 M; to noncontrolling interests: $763.00 K. ## Chart details: Revenue by Business Segment by Timing of Transfer - Page: https://plicit.ai/financials/crl/fy2026-ytd-q2-income-statement/revenue-by-business-segment-by-timing-of-transfer - Chart image: https://plicit.ai/charts/crl-fy2026-ytd-q2-revenue-by-business-segment-by-timing-of-transfer-sankey.png Income statement for 2025-12-28 through 2026-06-27. View: Segments by Timing of Transfer of Good or Service. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total revenue**: 1,999,908,000 US dollars - **Cost of revenue (calculated)**: 1,341,870,000 US dollars - **Gross profit (calculated)**: 658,038,000 US dollars - **Operating expenses (calculated)**: 418,253,000 US dollars - **Operating income**: 239,785,000 US dollars - **Other income (expense), net (calculated)**: negative 216,557,000 US dollars - **Income before income taxes**: 23,228,000 US dollars - **Provision for income taxes**: 38,790,000 US dollars - **Net income (loss)**: negative 15,562,000 US dollars - **Discovery and Safety Assessment Segment - Services and products transferred at a point in time**: 1,262,000 US dollars - **Discovery and Safety Assessment Segment - Services and products transferred over time**: 1,202,168,000 US dollars - **Manufacturing - Services and products transferred at a point in time**: 202,839,000 US dollars - **Manufacturing - Services and products transferred over time**: 175,797,000 US dollars - **Research Models and Services Segment - Services and products transferred at a point in time**: 229,269,000 US dollars - **Research Models and Services Segment - Services and products transferred over time**: 188,573,000 US dollars - **Cost of revenue (excluding amortization of intangible assets)**: 1,341,870,000 US dollars - **Amortization of intangible assets**: 29,934,000 US dollars - **Selling, general and administrative**: 388,319,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. - Of which attributable to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: −$16.33 M; to noncontrolling interests: $763.00 K. ## Chart details: Revenue by Geography - Page: https://plicit.ai/financials/crl/fy2026-ytd-q2-income-statement/revenue-by-geography - Chart image: https://plicit.ai/charts/crl-fy2026-ytd-q2-revenue-by-geography-sankey.png Income statement for 2025-12-28 through 2026-06-27. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total revenue**: 1,999,908,000 US dollars - **Cost of revenue (calculated)**: 1,341,870,000 US dollars - **Gross profit (calculated)**: 658,038,000 US dollars - **Operating expenses (calculated)**: 418,253,000 US dollars - **Operating income**: 239,785,000 US dollars - **Other income (expense), net (calculated)**: negative 216,557,000 US dollars - **Income before income taxes**: 23,228,000 US dollars - **Provision for income taxes**: 38,790,000 US dollars - **Net income (loss)**: negative 15,562,000 US dollars - **UNITED STATES**: 1,083,670,000 US dollars - **Europe**: 540,651,000 US dollars - **CANADA**: 237,075,000 US dollars - **Asia Pacific**: 115,998,000 US dollars - **Other**: 22,514,000 US dollars - **Cost of revenue (excluding amortization of intangible assets)**: 1,341,870,000 US dollars - **Amortization of intangible assets**: 29,934,000 US dollars - **Selling, general and administrative**: 388,319,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. - Of which attributable to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: −$16.33 M; to noncontrolling interests: $763.00 K.